Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease
- PMID: 36680450
- PMCID: PMC9893704
- DOI: 10.14744/AnatolJCardiol.2022.2333
Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease
Comment in
-
Reply to Letter to the Editor: 'Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease'.Anatol J Cardiol. 2023 Jan;27(1):56-58. doi: 10.14744/AnatolJCardiol.2022.2335. Anatol J Cardiol. 2023. PMID: 36680451 Free PMC article. No abstract available.
Comment on
-
Oral Anticoagulant Use and Long-Term Follow-Up Results in Patients with Non-valvular Atrial Fibrillation in Turkey AFTER-2 Study.Anatol J Cardiol. 2022 Jul;26(7):567-576. doi: 10.5152/AnatolJCardiol.2022.1597. Anatol J Cardiol. 2022. PMID: 35791713 Free PMC article.
References
-
- Lodziński P, Gawałko M, Budnik M.et al. Trends in antithrombotic management of patients with atrial fibrillation. A report from the Polish part of the EURObservational Research Programme - atrial fibrillation General Long-Term Registry. Pol Arch Intern Med. 2020;130(3):196 205. 10.20452/pamw.15157) - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical